The global epidemic of tuberculosis (TB) imposes a sustained epidemiologic vigilance and
investments in research by governments. Mycobacterium tuberculosis, the main causative …

Mycobacterium tuberculosis is considered one of the most successful pathogens and
multidrug‐resistant tuberculosis, a disease that urgently requires new chemical entities to be …

Over the past 2000 years, tuberculosis (TB) has claimed more lives than any other infectious
disease. In 2020 alone, TB was responsible for 1.5 million deaths worldwide, comparable to …

In this Miniperspective we broadly cover the recent developments and strategies that are
being adopted globally in the battle to urgently discover and develop new drugs to treat …

Highlights•In 2018 1.2 million people died of tuberculosis.•The ideal drug candidate should
be active against replicating and nonreplicating Mycobacterium tuberculosis.•New drug …

Mycobacterium tuberculosis is a difficult pathogen to combat and the first-line drugs currently
in use are 40–60 years old. The need for new TB drugs is urgent, but the time to identify …

Tuberculosis (TB) is an infectious disease caused by the pathogen Mycobacterium
tuberculosis (M. tuberculosis), killing about two million people worldwide each year. An …

Conspectus Tuberculosis (TB) is the leading cause of mortality globally resulting from an
infectious disease, killing almost 1.6 million people annually and accounting for …

Tuberculosis (TB) is a severe infectious disease worldwide. The increasing emergence of
drug‐resistant Mycobacterium tuberculosis (Mtb) has markedly hampered TB control …

Tuberculosis is a major global health problem. In the middle of the last century several
laboratories identified, developed and synthesized several substances which were active …